Market Quotes

2281 items in section

Orion S.A. Shares Plunge on Wider-Than-Expected Fourth-Quarter Loss

Orion S.A. stock plummeted 18% on Tuesday after the carbon black supplier reported a significant fourth-quarter loss and issued a 2026 outlook that trailed Wall Street projections. Despite beating revenue estimates, the company’s widening adjusted loss triggered a sharp sell-off, extending a year-long decline for the industrial materials firm.

Valero Flags Potential Flaring at 218,700 BPD Houston Refinery

Valero Energy issued a notification on Tuesday regarding potential flaring at its Houston refinery as the facility begins a period of maintenance work. The alert, disseminated through the East Harris County Community Awareness Emergency Response system, serves as a standard precautionary measure for residents near the industrial corridor.

Amex Global Business Travel Surges on Q4 Profit and $600M Buyback

American Express Global Business Travel (GBT) shares climbed Tuesday after the company swung to a fourth-quarter profit that significantly outperformed Wall Street expectations. The travel management leader reported robust revenue growth and doubled its share repurchase program to $600 million, reflecting executive optimism regarding its AI-driven strategy and market position.

eToro Shares Surge 18% Following Q4 Earnings Beat

eToro Group shares rallied on Tuesday after the social trading platform posted fourth-quarter adjusted earnings that surpassed Wall Street estimates. Despite a significant contraction in cryptocurrency-related revenue, the company’s bottom line benefited from a profit increase and a newly expanded $100 million share-buyback program.

Health Canada Clears Merck’s Under-the-Skin Version of Keytruda

Health Canada has granted regulatory approval for Merck’s subcutaneous formulation of its blockbuster immunotherapy, Keytruda, providing a faster alternative to traditional intravenous infusions. The decision follows clinical data demonstrating that the under-the-skin injection matches the efficacy and safety profile of the original IV treatment for specific lung cancer patients.

Lufax Shares Surge 17% as Xiang Ji Appointed Next CEO

Lufax Holding Ltd. shares jumped on Tuesday after the company named Co-Chief Executive Xiang Ji as its next CEO, effective April 1. The leadership transition follows the decision by current chief Yong Suk Cho to step down after his contract expires at the end of March.

Itron Stock Surges as Q4 Earnings and Revenue Beat Estimates

Itron shares jumped double digits on Tuesday after the infrastructure technology company reported fourth-quarter financial results that topped Wall Street expectations across the board. The rally pushed the stock to $100.25, marking a significant recovery for a firm that had seen modest gains over the previous year.

Franklin Electric Shares Sink on Disappointing Full-Year Outlook

Shares of Franklin Electric tumbled 13% on Tuesday after the pumping systems manufacturer issued a 2024 financial outlook and fourth-quarter results that failed to meet Wall Street expectations. The sell-off drove the stock to $95.19, marking a significant retreat as the company’s projected earnings fell well below analyst consensus.

Spain Orders Probe Into X, Meta, and TikTok Over AI-Generated Abuse

The Spanish government has called for a criminal investigation into X, Meta, and TikTok, accusing the social media giants of failing to prevent the viral spread of AI-generated child pornography. Minister Elma Saiz announced the move on Tuesday, citing the discovery of millions of explicit deepfake images involving minors that circulated online in less than two weeks.

Elliott Builds 10% Stake in Norwegian Cruise Line to Drive Overhaul

Activist investor Elliott Investment Management has accumulated a stake exceeding 10% in Norwegian Cruise Line Holdings, signaling a push for strategic changes to reverse years of market underperformance. The move sent shares of the Miami-based cruise operator climbing 6.1% to $22.80 in premarket trading on Tuesday.

BAE Systems Targets Growth as Global Defense Spending Surges

BAE Systems is expected to report a significant rise in annual revenue and profit this Wednesday, bolstered by a massive order backlog for fighter jets and combat vehicles. As global defense spending intensifies, analysts project the London-listed manufacturer will see sales grow by up to 10%, following a year marked by major contract wins in Europe and the Middle East.

Marriott Vacations Names Matt Avril Permanent CEO, Taps Mike Flaskey

Marriott Vacations Worldwide has solidified its leadership team by naming Matt Avril as its permanent chief executive officer, stripping the interim title he has held since November. Alongside the appointment, the vacation-ownership giant recruited former Hornblower Group head Mike Flaskey to serve as president and chief operating officer, signaling a push for stability following the transition.

Arizona Sonoran to Go Solo on Cactus Project After Nuton Exit

Arizona Sonoran Copper has terminated its joint venture option with Rio Tinto-backed Nuton, opting to advance its flagship Cactus Project independently. The Toronto-listed developer reached a mutual agreement to end the partnership on the Arizona-based site, triggering a series of cash payments to Nuton totaling up to $35 million.

Gary Bowman to Step Down as Bowman Consulting Group CEO

Gary Bowman, the founder of Bowman Consulting Group, will retire as chief executive and board member of the Reston, Virginia-based firm. The transition, expected to conclude once a successor is appointed, concludes a nearly 30-year tenure at the helm of the engineering-services company.

Compass Pathways Surges as Psilocybin Therapy Hits Phase 3 Goals

Compass Pathways shares jumped 34% in premarket trading Tuesday after the biotechnology firm announced its psilocybin-based treatment for depression met primary endpoints in a second Phase 3 clinical trial. The results for the COMP360 therapy offer a potential breakthrough for patients with treatment-resistant depression, a condition historically difficult to manage with existing pharmaceuticals.

IHS Towers to Offload Latin American Business to Macquarie for $952M

IHS Towers has reached an agreement to sell its Latin American operations to Macquarie Asset Management in a deal valued at an enterprise value of $952 million. The transaction includes the company’s entire footprint in Brazil and Colombia, signaling a strategic pivot for IHS as Macquarie doubles down on the region's digital infrastructure.

Xerox Secures $450 Million in TPG Deal to Fuel Strategic Pivot

Xerox Holdings Corp. has raised $450 million through a joint venture with asset management firm TPG, securing a mix of senior secured term loans and preferred equity. The deal, announced Tuesday, marks a critical step in the legacy print giant’s effort to shore up its balance sheet and fund a broader corporate "reinvention."

Fairfax to Take Kennedy-Wilson Private in $1.65 Billion Buyout

Fairfax Financial Holdings has reached an agreement to acquire real estate investment firm Kennedy-Wilson Holdings in an all-cash deal led by a consortium of top executives. The transaction, which values the company at a significant premium, will see the firm delisted from the New York Stock Exchange by mid-2026.

Labcorp Q4 Profit Climbs on Resilient Diagnostics Demand

Labcorp reported a rise in fourth-quarter profit on Thursday, fueled by steady growth in its core diagnostic laboratories business. While the company's $3.52 billion in revenue narrowly missed Wall Street estimates, its adjusted earnings of $4.07 per share surpassed analyst expectations, supported by a 5.5% revenue jump in clinical testing.

DTE Energy Beats Estimates as Q4 Profits Climb to $369 Million

DTE Energy exceeded Wall Street expectations in the fourth quarter, reporting a net income of $369 million driven by robust performance across its electric and gas utility divisions. The Detroit-based energy provider posted earnings of $1.77 per share, a significant jump from the $292 million recorded during the same period last year.

Honeywell Trims Full-Year Profit Figures on $436 Million Charge

Honeywell International has revised its full-year 2024 financial results downward following significant post-report charges, primarily a $436 million goodwill impairment within its industrial-automation segment. The industrial conglomerate updated its net income and operating margins on Tuesday, though it maintained its long-term growth targets for 2026.

Genuine Parts Extends Dividend Growth Streak to 70 Years

Atlanta-based Genuine Parts announced a 3.2% increase to its quarterly dividend on Tuesday, marking seven decades of consecutive payout growth. The distributor of automotive and industrial parts raised the distribution to $1.0625 per share, cementing its status as one of the most consistent yield-payers in the S&P 500.

FDA Grants Priority Review to Bristol Myers Myeloma Drug Iberdomide

The U.S. Food and Drug Administration has accepted Bristol Myers Squibb’s application for iberdomide, granting it priority review for the treatment of relapsed or refractory multiple myeloma. The decision positions the therapy as a potential first-in-class treatment for patients whose blood cancer has returned or failed to respond to existing standard-of-care regimens.

SAIC Names James Reagan Permanent CEO to Lead Tech Integrator

Science Applications International Corp. has formally appointed James Reagan as its permanent chief executive officer, concluding a thorough search process to stabilize leadership at the Reston, Virginia-based technology firm. Reagan, who has served as interim CEO since October, steps into the role permanently following the departure of his predecessor last year.